For now, the best path forward is to stick with therapies backed by solid, long-term data, using GLP-1 agonists as a potential supplement for managing metabolic issues
Alexander Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST Understanding GLP-1 Biology: Why These Agents Work When I began integrating incretin-based therapies into broader metabolic programs, appreciating the underlying physiology transformed how I select, titrate, and support these medications
Once the pharmacy ships your meds, the actual cost will be displayed for the respective refill
Sener S, Akbas A, Kilinc F, Baran P, Erel O, Aktas A
Improvements in waist size also appeared in the diabetes group